TP Therapeutics Announces Interim Data from the Phase 1/2 Clinical Trial of Investigational Agent TPX-0005 at ASCO 2018: Data Presented from the Ongoing TRIDENT-1 Study


“TPX-0005 has demonstrated clinically meaningful and durable benefit in patients with ROS1 fusion-positive lung cancers and NTRK fusion-positive tumors,” said Alexander Drilon, M.D., a key investigator in the TRIDENT-1 Study and Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center. “I continue to be encouraged by the preliminary antitumor activity … Continue reading TP Therapeutics Announces Interim Data from the Phase 1/2 Clinical Trial of Investigational Agent TPX-0005 at ASCO 2018: Data Presented from the Ongoing TRIDENT-1 Study

Op volle toeren.


Originally posted on Eddie's Rollercoaster:
De rollercoaster loopt weer op volle toeren. Afgelopen woensdag op en neer naar Keulen geweest voor hun visie op de nieuwe ontwikkelingen binnen en buiten mijn lichaam. Op de hersenscan zijn dus 6 plekken te zien die daar niet thuis horen. Flinke tegenvaller! Het is zaak deze ‘krakers’ snel…

November is Lung Cancer Awareness Month!! (& an update!)


Originally posted on from lizzie's lungs:
November is lung cancer awareness month and you can wear white to help support and create awareness!  This month, I wanted to try and create awareness in my own way. I’ve designed my own Lung Cancer Awareness Bracelets that are available to purchase online starting today! ALL PROCEEDS…